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ABSTRACT
￿
A 70,000-mol-wt protein was isolated from A431 carcinoma cell extracellular matrix
that promotes cell substratum adhesion of these epidermoid tumor cells. Extracellular matrix
was isolated by a modification of a procedure described by Hedman et al. (Hedman, K ., M .
Kurkinen, K. Alitalo, A. Vaheri, S . Johansson, and M. H66k, 1979 /. Cell Biol., 81 :83-91) and
Yamada and Weston (Yamada, K., and J . A. Weston, 1974, Proc. Nati. Acad. Sci. USA, 71 :3492-
3496). Cells were solubilized with 0.5% deoxycholate, 10 mM Tris, 0.9% NaCl, and 1 mM
phenylmethylsulfonyl fluoride, pH 8.0 . The residual matrix was then removed from the plates
with 6 M urea and 1 mM phenylmethylsulfonyl fluoride and phosphate-buffered saline.
SDS PAGE gels of the 6 M urea extract showed one major band at 70,000-mol-wt by
Coomassie Blue staining. A 70,000-mol-wt isotopically-labeled band could also be extracted
from the matrix of cells incubated with ["S]methionine . Because of the presence of this
protein on squamous-derived epithelial cells we have called the 70,000-mol-wt molecule
epinectin. Indirect immunofluorescence with polyclonal rabbit antibodies against epinectin
stained A431 cells pericellularly in dense punctate accumulations and along the plasma
membrane . Enzyme-linked immunoassays and gel-transfer immunolocalization studies showed
that the extract did not cross-react with antibodies to fibronectin, laminin, serum-spreading
factor, epibolin, or keratin. Additionally, antibodies to epinectin did not cross-react with these
proteins . Further studies showed that epinectin does not bind to gelatin . Cell-adhesion assay,
using radiolabeled A431 carcinoma cells on various adhesion-promoting substrates, showed
that epinectin has similar adhesion-promoting capacity as serum-spreading factor, was some-
what less active than fibronectin, but more effective than laminin or epibolin. Epinectin
appears to be a unique protein isolated from epidermoid tumor cells that is distinct from other
known adhesion proteins.
Cell adhesion is a complicated phenomenon with profound
biological significance. Cell-substratum attachment is in-
volved in development, wound healing, cell migration, in-
flammation, and metastasis. Various molecules, such as gly-
coproteins, proteoglycans, and glycosyl transferases, may be
involved in the attachment of cells to matrices. Much effort
has focused on glycoproteins present either in serum, base-
ment membranes, or the cell matrix produced by cells in
culture. At present, a limited number of glycoproteins, in-
cluding fibronectin (1), laminin (2), epibolin (3), serum-
spreading factor (SSF)' (4), and a 140,000-mol-wt glycopro-
'Abbreviations used in this paper: BSA, bovine serum albumin;
DME, Dulbecco's modified Eagle's medium; ELISA, enzyme-linked
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tein (5) are known to mediate attachment. These adhesion
proteins are often of high molecular weight, have disulfide
bonding, and sometimes exist in multimeric forms. Fibronec-
tin is a disulfide-bonded, 440,000-mol-wt protein present in
plasma, cell matrices, and basal lamina (for reviews see ref-
erences 1, 6). Fibronectin promotes the adhesion and migra-
tion ofa variety of cell types. Studies have shown that specific
regions of the fibronectin molecule bind to collagen, heparan
sulfate, and fibrin, or have other unique functions (1, 6). A
small peptide fragment of fibronectin has been observed to
promote the attachment of cells (7). Laminin is a disulfide-
immunosorbent assay; PBS, phosphate-buffered saline; SSF, serum-
spreading factor.
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0 The Rockefeller University Press - 0021-9525/84/08/0464/07 $1 .00bonded, 850,000-mol-wt protein composed of subunits of
400,000 and 200,000 mol wt. Laminin is located in basement
membranes throughout the body, including vascular, glomer-
ular, and pulmonary basement membranes, etc. (6, 8, 9).
Laminin promotes the attachment of epithelial cells to type
IV collagen (2) and promotes the adhesion ofhighly metastatic
tumor cells to substrata (10). Original studies proposed that
laminin could only promote cell attachmentofepithelialcells.
However, in more recent studies, laminin promoted attach-
ment of cells of nonepithelial origin (11), and, in fact, is
produced by fibrosarcoma cellsand perhaps fibroblasts (12).
Two other adhesion-promoting molecules are epibolin and
SSF. Epibolin is a 65,000-mol-wt protein, originally isolated
from human plasma (3). The location of epibolin in tissues
has not been determined. Epibolin promotes epithelial, spe-
cifically epidermal cell movement and spreading (3). SSF
consists of 65,000- and 75,000-mol-wt proteins. It can be
isolated from serum, platelets, and placenta. SSF promotes
adhesion and spreading of a wide variety of cells of diverse
origins (4).
It is possible that some attachment molecules are tissue or
function specific, or that several molecules may act in concert
to promote adhesion of any one cell. Our laboratory and
others have tried to isolate novel molecules from the extra-
cellular milieu that may be involved in the cell-attachment
process. This report describes the isolation and characteriza-
tion of a new cell attachment protein derived from the A431
epidermoid carcinoma line (13). This cell line was derived
from a vulvar squamous carcinoma and has been studied
extensively by laboratories working on epidermal growth fac-
tor receptors (14). The protein produced by these cells pro-
motes significant attachment ofthe A431 cells and is distinct
by functional and immunoassays from laminin, fibronectin,
epibolin, and SSF. Indirect immunolluorescent staining of
cells in vitro with antibodies produced to this protein show
the protein to be distributed along the cell membrane and
also in dense pericellular accumulations.
MATERIALS AND METHODS
Cells:
￿
A431 carcinoma cells were purchased from Meloy Laboratories
(Springfield, VA). This cell line was originally isolated from a vulvarcarcinoma
(13). Cells were grown in 75-cm' Falcon flasks (Falcon Lobware, Oxnard, CA)
in Dulbecco's modified Eagle's medium (DME) (Gibco Laboratories, Grand
Island Biological Co., Grand Island, NY) with 6% fetal calf serum (Flow
Laboratories, Rockville, MD) at 37°C, 5% COz, and passaged at confluence at
a 1 :10 ratio every 4 d.
Isolation of Matrix:
￿
The cell matrix was extracted from confluent
layers ofA431 carcinoma cells using a modification ofthe urea extract proce-
dure described (15, 16). Cells were grown for 4 d (until confluence) in DME
with 6% fetal calf serum, rinsed three times with serum-free DME, fed with
serum-free medium and grown for an additional 2 d. To extract matrix, we
first rinsed cells three times with Dulbecco's phosphate-buffered saline (PBS)
at room temperature, then treated with 0.5% deoxycholate-sodium salt (Sigma
Chemical Co., St. Louis, MO), 0.9% NaCl, 1 mM phenylmethylsulfonyl fluo-
ride (Sigma Chemical Co.), 10 mM Tris buffered at pH 8.0. Flasks were rotated
vigorously on a Tektator V (American Scientific Products, McGaw Park, IL)
rotating platform at room temperature for 10 min, the supernatant discarded,
and the treatment repeated two additional times. Studies have shown that what
remains after this orsomewhat similar treatment is an extracellular matrix (15,
16). This residual matrix was rinsed with PBS, pH 7.4, and then extracted with
6 M urea in PBS with 1 mM phenylmethylsulfonyl fluoride for 2-3 h at 37°C.
The urea soluble extract was dialyzed extensively against PBS, pH 7.4, and
concentrated by evaporation. Extracts were analyzed by 7.5% SDS PAGE with
a 5% stacking gel, using formulations of Blattler et al. (17), and the Laemmli
buffer system (18).
Metabolic Labeling:
￿
A431 cells were rinsed in serum-free medium
after 4 d in culture and labeled for 2 d with 25 IACi/ml ["S]methionine
(New England Nuclear, Boston, MA; specific activity 1,220 Ci/mMol). Radio-
labeled cells were treated as described above to isolate cell matrices and
radiolabeled proteins were similarly extracted with urea. Conditioned medium
and cell extracts were analyzed on SDS PAGE with a 5% stacking gel and a
7.5% running gel. Autoradiography was performed by treating gels with
En'Hance (New England Nuclear), followedby drying, and exposure ofKodak
XAR5 autoradiography film.
Antibody Production:
￿
The urea extract of the cell matrix was elec-
trophoresed on 7.5% SDS polyacrylamidegelsand a predominant 70,000-mol-
wt protein was observed. The 70,000-mol-wt band was cut from the gel and
protein was electrophoretically eluted from the polyacrylamide into small
dialysis bags, concentrated by evaporation and injected subcutaneously every
2 wk into New Zealand white rabbits. The initial injection was in complete
Freund's adjuvant (Cappel Laboratories, West Chester, PA) and all subsequent
injections were in incomplete Freund's adjuvant (Gibco Laboratories,
Grand Island, NY). Antibody titers were assayed by enzyme-linked immunoas-
say (ELISA). Studies showed that rabbits developed antibodies to the 70,000-
mol-wt protein and also to albumin, which presumably was present in trace
quantities (from serum in growth medium) in the original immunizing prepa-
ration. Therefore, antisera was purified on an affinity column ofbovine serum
albumin (BSA)-Affigel 10 (Bio-Rad Laboratories, Richmond, CA) prepared as
recommended by the manufacturer; this removed contaminating antialbumin
antibodies and the residual antibody not binding albumin was used in all
further studies.
Additional Antibodies: Affinity-purified antibodies to fibronectin
and laminin were prepared in this laboratory and previously characterized by
Palm and Furcht (19). These antibodies were used to rule out the possibility
that the 70,000-mol-wt protein was a proteolytic fragment of either higher
molecular weight cell-adhesion molecule. Antihuman keratin was purchased
from Accurate Scientific and Chemical Co. (Westbury, NY), anti-BSA antibod-
ies were purchased from Cappel Laboratories (West Chester, PA). Because the
70,000-mol-wt protein derived from A431 cells has attachment promoting
activities, as described below, studies were performed to ascertain any similarity
of the protein with SSF and epibolin, proteins with similar activities and
approximately similar molecular weights. The antigens and antibodies to SSF
were kindly provided by Dr. David Barnes (University of Pittsburgh) and to
epibolin by Dr. Kurt Stenn, (Yale University).
ELISA were performed as described (20), using primary antisera to the
70,000-mol-wt protein, fibronectin, laminin, SSF, epibolin, keratin, and albu-
min, starting at 1 :100 dilution; this was then followed by a 1 :500 dilution of
peroxidase-conjugated goat anti-rabbit immunoglobulin G (Cappel Laborato-
ries). Additional studiescharacterized the cell matrix preparation by gel-transfer
immunolocalization (Western blots) as previously described (21). An "immu-
nodot" analysis was also performed, which is very similar to gel-transfer
immunolocalization, except that solutions of purified proteins are applied
directly to nitrocellulose rather than being transferred from gels. Localization
with antibodies is performed identically in each procedure (19).
Immunofluorescence:
￿
Cells were grown on glass coverslips for 2 d
past the point of confluence and then fixed with 3% formaldehyde in PBS.
Cells were rinsed five times in PBS with Ca" (0.68 mM CaCIA then reacted
with a 1 :20 dilution of antibodies for '/z h in a humidified atmosphere. Cells
were rinsed five times in PBS-Ca" and reacted with a 1 :40 dilution of
rhodamine conjugated goat anti-rabbit immunoglobulin G (Cappel Laborato-
ries) followed by five rinses in PBS-Ca". Fluorescence was observed on a Zeiss
Universal microscope with an epifluorescence attachment and photographed
with 3M ISO 1000 color slide film (3M, St. Paul, MN).
Cell Adhesion:
￿
A431 cells were radiolabeled for 1-2 d with 25 IACi/
ml of 'H-amino acids (ICN Radiochemical, Irvine, CA) in serum-free medium
and then harvested at 80-100% confluence. Cells were washed free of radiola-
beled free amino acids, released with trypsin, and trypsin was inhibited with 1
mg/ml soybean trypsin inhibitor (Sigma Chemical Co.). Cells were diluted to
5-8 x 10' cells/ml in DME with HEPES buffer and then 1 ml of a cell
suspension was placed in each well. Before this, wells of24 well dishes (Costar,
Cambridge, MA) were coated for 2 h at 37°C with test proteins diluted in 0.05
M sodium carbonatebuffer, pH 9.6. Wells were then coated for 3 h with 5 mg/
ml BSA (Miles Lab, Elkhart, IN) to minimize any nonspecific adhesion. Trip-
licate samples of cells were incubated for 45 min at 37°C. Wells were then
rinsed three times with PBS-Ca" to remove unattached cells. Radiolabeled
attached cells were solubilized in 1 % SDS, 0.5 N NaOH, dissolved in Aquasol
2 (New England Nuclear), and then radioactivity was quantitated with a Beck-
man LS 230 Scintillation System. For antibody-blocking experiments, immu-
noglobin fractions of anti-70,000-mol-wt serum and preimmune serum were
purified by DEAF (Whatman, Kent, England) batch processing. Antiepinectin
and preimmune serum were both concentrated six times over the original sera
and used at equivalent concentrations in antibody-blocking experiments. An-
tifibronectin and antilaminin were used in a range that completely blocks cell
adhesion on fibronectin and laminin, respectively.
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Preparation :
￿
The ability ofthe 70,000-mol-wt protein isolated from A431
cells to bind to gelatin was assessed on a gelatin-agarose column made as
described (22). A preparation of the 70,000-mol-wt protein was applied to the
column (2 x 1 cm) in PBS with approximately equal amounts of fibronectin,
which is known to bind gelatin. The sample was eluted with either 1 M NaBr,
0.02M Na acetate, pH 5 .0, orwith6M urea in PBS . Sampleswere concentrated
by precipitation with 4 vol ofcold acetone and precipitates isolated by centrif-
ugation in a Beckman centrifuge model .12-21 at 30,000 g for 15 min . Precipi-
tates were resuspended in reducing sample buffer (3% SIDS, 0.66 M Tris, pH
6 .8, 15% glycerol, 0.01% Bromophenol Blue + 5% beta-mercaptoethanol) and
run on SDS PAGE .
RESULTS
The cell matrix was isolated from A431 carcinoma cells .
SDS PAGE analysis ofthe matrix and Coomassie Blue stain-
ing showed one major band with a nonreducedM r of 53,000
(Fig. 1 b) and reduced M r of 70,000 (Fig . 1 c) . Metabolic
labeling of cells with [ 35S]methionine showed incorporation
into the 70,000-mol-wt protein, indicating that cells were
synthesizing this molecule rather than passively adsorbing it
from serum (Fig. 2 b) . Residual material left after urea extrac-
tion was solubilized with reducing sample buffer. This residue
had decreased intensity of the"S-labeled 70,000-mol-wt band
compared to a number of other bands (Fig . 2 d). In addition
to the 70,000-mol-wt band in the matrix, a 70,000-mol-wt,
["S]methionine-labeled molecule was secreted into the cul-
turemedium (Fig. 2 c) . The fact that other radiolabeled bands
appearin Fig . 2 b while only one Coomassie Blue band appears
in Fig . 1 c suggests limited methionine incorporation into the
protein, while its observed accumulation over time is seen in
Fig . 1 c .
Antibodies to the 70,000-mol-wt protein were made in
rabbits but showed additional reactivity to BSA presumably
present in trace amounts (from serum in the culture medium)
at the approximateMrofthe 70,000 protein usedto immunize
the rabbits. Therefore, BSA affinity columns were used to
absorb out these antibodies . The remaining antibodies, which
had activity against the 70,000-mol-wt protein, did not react
with albumin by ELISA (data not shown) .
Immunofluorescence using the purified anti-70,000-mol-
wt antibodies showed the 70,000-mol-wt protein to have a
pericellular distribution in cultures of A431 cells grown in
vitro (Fig . 3) . Two pericellular staining patterns were ob-
served : a plasma membrane linear reaction and dense punc-
tate extracellular accumulations (Fig. 3, a and c). The intensity
FIGURE 1 7.5% SDS polyac-
rylamide gel : Coomassie Blue
stain . (a) Molecular weight
standards (x 10-3 ) : fibronectin
(220), phosphophorylase A
(93), BSA (68), and ovalbumin
(43) . (b) Urea-extracted cell
matrix A431 cells : unreduced .
(c) Urea-extracted cell matrix
A431 cells : reduced . Approxi-
mately 50 tcg protein per lane .
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FIGURE 2
￿
Fluorograph of 7.5% SDS polyacrylamide gel . All lanes
show [ 35S]methionine labeled proteins . (a) Urea-extracted matrix :
unreduced . (b) Urea-extracted matrix : reduced . (c) Conditioned
medium : reduced . (d) Posturea extract. Residue solubilized in re-
ducing sample buffer . Asterisk indicates 70,000-mol-wt, epinectin
molecule . 9,000 cpm per lane .
of this globular extracellular reaction varied within the cell
population ; some areas of the culture stain intensely, while
others lacked these extracellular globular deposits and had
only the membrane staining. Staining with normal rabbit
serum showed nominal reactivity and did not produce this
pattern (Fig. 3e) . Immunofluorescent staining of A431 cells
with antibodies to laminin and fibronectin also showed min-
imal reaction (data not shown) . Additional immunofluores-
cence studies were performed to determine the presence of
SSF or epibolin . No reactivity was observed against these
proteins (data not shown) .
The 70,000-mol-wt pericellular protein shows no reaction
with antibodies to fibronectin, laminin, SSF, epibolin, and
human keratin by ELISA orimmunodot analysis (Fig. 4) . To
further show that the 70,000-mol-wt band is distinct from
these molecules and that antibody raised against 70,000-mol-
wt is specific for 70,000-mol-wt molecule, gel-transfer im-
munolocalization (Western blots) were performed . The anti-
70,000-mol-wt antibody reacts against the pericellular mate-
rial derived from A431 cells and not to the other previously
defined matrix molecules or attachment proteins such as
laminin or fibronectin . Controls in these experiments showed
reactivity of other antibodies to their respective antigens, i.e .,
antilaminin with laminin (data not shown) .
A 70,000-mol-wt glycoprotein isolatedby gelatin-Sepharose
affinity chromatography from the culture medium of various
cell types has been described (23). To show that the 70,000-
mol-wt-derived glycoprotein from A431 cells was distinct
from this gelatin-binding glycoprotein, we ran approximately
equal amounts ofthe A431 derived "matrix" preparation and
fibronectin over a gelatin-Sepharose column . As shown in
Fig . 5 b, the 70,000-mol-wt protein did not bind and came
through in the void volume, while the fibronectin bound to
the column and could be eluted with urea (Fig. 5 c) .FIGURE 3
￿
Phase-contrast and indirect immunofluorescence microscopy of A431 cells . Cells were grown to postconfluence on
glass coverslips and fixed in 3% formaldehyde. (a) Immunofluorescent staining with antiepinectin antisera . X 500 . (b) Phase-
contrast micrograph of a . x 500 . (c) Immunofluorescent staining with antiepinectin showing globular extracellular deposits . x
500 . (d) Phase contrast of (d) . x 500 . (e) Immunofluorescent staining control with preimmune normal rabbit serum . x 500 . (f)
Phase-contrast micrograph of a . X 500 . Bar, 5 pm .
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FIGURE 4
￿
Summary of ELISA and gel-transfer immunolocalization
analysis . All antibody reactions are at 1 :100 dilution . a indicates
antibodies to the various proteins . SSF, serum-spreading factor .
FIGURE 5 Gelatin-Sepha-
rose affinity chromatogra-
phy using similar concen-
trations of fibronectin and
urea extracted matrix from
A431 cells containing epi-
nectin . 7.5% SDS polyac-
rylamide gel . (a) Molecular
weight standards (x 10_'):
fibronectin (220), phos-
phorylase A (93), BSA (68),
and ovalbumin (43) . (b)
Unbound materials : con-
taining mainly epinectin in
the void volume . (c) Bound
material : eluted with 8 M
urea : mainly fibronectin .
Cell Attachment
Epinactin SSF Epibolin LanliMn Fibrometin
The ability of the matrix extract to promote A431 cell
attachment was compared to the known attachment mole-
cules : laminin, fibronectin, SSF, and epibolin . Various con-
centrations of extract were coated in test wells and then the
number of cells adhering was measured after 45 min . The
exact concentrations of the 70,000-mol-wt extract and of
epibolin were difficult to precisely ascertain as these prepara-
tions have not been purified to absolute homogeneity . How-
ever, these as well as the other proteins were assayed at or
near their maximal adhesion-promoting activity. Therefore,
Fig. 6 shows that the efficacy of the 70,000-mol-wt matrix
extract in promoting cell adhesion is similar to that of 1-10
,ug/mlSSF but somewhat less effective than fibronectin . Lam-
inin was less efficient than the 70,000-mol-wt protein in
promoting attachment ofA431 cells, and epibolin was totally
ineffective . It is important to note that the 70,000-mol-wt
extract used in this assay has no reactivity with antibodies to
fibronectin, laminin, epibolin, or SSF by ELISA (Fig . 4) .
Experiments were performed by preincubating cells with 10
jug/ml cycloheximide for 3 h . Then cell-adhesion assays were
performed in the presence of cycloheximide . These studies
showed that the adhesion of cycloheximide-treated cells to
epinectin or fibronectin was slightly >50% of the adhesion to
either protein in the absence of cycloheximide (data not
shown) . Therefore, these data suggest that epinectin can func-
tion directly as a cell-adhesion protein for these cells . Fig . 7
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FIGURE 6 Cell attachment assay using A431 cells . Cells were la-
beled for 1 d with 'H amino acids . Tissue culture plates were coated
for 2 h with the test protein, washed, and then coated for an
additional 3 h with 5 mg/ml BSA. Plates were washed and cells
were incubated on coated wells for 45 min . All tests were done in
triplicate . Bars represent one standard deviation and data represents
percent of cells added that adhered .
FIGURE 7
￿
Antibody-mediated inhibition of cell adhesion on epi-
nectin coated plates . Tissue culture plates were incubated as in Fig .
6 with the 70,000-mol-wt matrix protein and then with BSA . Plates
were then incubated for 1 h with the appropriate antibodies . Cell
binding to the 70,000-mol-wt protein alone with no antibody added
was termed 100% . All cell binding in the presence of antibodies is
expressed as a percent of this value . Bars represent one standard
error of the mean . Aby, antibody.
shows that antibodies to epinectin inhibit40% ofcell adhesion
on the 70,000-mol-wt matrix extract, whereas immunoglob-
ulins from preimmune serum, and antibodies to laminin and
fibronectin do not block cell adhesion on the 70,000-mol-wt
matrix extract.
This study defines anew cell surface and pericellular molecule
produced by human epidermoid squamous carcinoma cells,
the A431 carcinoma cell line . This protein was extracted from
cell layers/cell matrices by 6 M urea and had aM1 of 70,000
on SDS PAGE under reducing conditions . The 70,000-mol-
wt protein was synthesized de novo by cells as shown by
I35S]methionine incorporation in metabolic labeling studies .
Antibodies to this 70,000-mol-wt protein were used for im-
munofluorescence studies and showed two staining patterns :
(a) a thin line virtually tracing the plasma membrane, and (b)
dense pericellular punctate accumulations adjacent to the
cells . Studies were performed that showed that the 70,000-
mol-wt molecule was extremely potent in promoting cell
adhesion . This 70,000-mol-wt molecule promoted attachment
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Aby Aby Abyof A431 cells at levels less than that of fibronectin, equal to
that of SSF, and substantially better than laminin or epibolin.
Adhesion-promoting activity in the presence ofcycloheximide
provided evidence that epinectin was acting directly as a cell-
adhesion molecule, rather than releasing endogenous stores
of adhesion factors. Preliminary studies of human tissue sec-
tions show specificity of antiepinectin antibodies for squa-
mous epithelium (for example, tongue and skin) as opposed
to other tissues.
It was important to show whether there was any relationship
between this 70,000-mol-wt molecule and any other known
cell adhesion, basement membrane, or cell-matrix glycopro-
teins. Antibodies to the 70,000-mot-wt protein showed no
cross reactivity by ELISA, dot immunoassay, or gel-transfer
immunolocalization to the following cell-adhesion and/or
matrix molecules: laminin, fibronectin, SSF, and epibolin,
Correspondingly, antibodies to laminin, fibronectin, SSF, and
epibolin did not react with the 70,000-mol-wt protein by
ELISA, dot immunoassays, or gel immunolocalization. The
70,000-mol-wt protein did not seem to be a proteolytic pro-
duct of larger cell-matrix glycoproteins because polyclonal
antibodies possessing numerous specificitiesdid not react with
the 70,000-mol-wt protein. On the basis ofthe above studies
it would appear that the 70,000-mol-wt adhesion-promoting
molecule is distinct from other known adhesion molecules.
Because this 70,000-mol-wt molecule promotes cell adhesion
and is an epithelial cell membrane and pericellular molecule,
we would term it epinectin.
Cell surface molecules with Mr
￿
70,000 have been isolated
by several groups by producing antibody to either whole
neural retina cells (24), neural cell surface (25), or conditioned
medium fractions from mammary epithelium cells (80,000
mol wt) (26). In these cases the molecules can then be isolated
by their ability to bind to these antibodies. These molecules
in the
￿
70,000-80,000-mol-wt range have been implicated in
cell-cell rather than cell-substratum adhesion.
A number of molecules have been isolated from cell mat-
rices or cell surfaces with Mr 70,000. We have been able to
distinguish some of these from epinectin, while others await
further experimentation. A 70,000-mol-wt glycoprotein has
been isolated by gelatin affinity chromatography from con-
ditioned medium ofa variety ofcellsin culture (23). Epinectin
from the A431 carcinoma cells seems distinct from this mol-
ecule as it does not bind to gelatin. Antibodies to epinectin
did not react with keratin, another protein of potential con-
cern that has components of 70,000-mol-wt (27), and corre-
spondingly, antibodies to keratin did not react with epinectin.
Early antibody preparations to epinectin were contaminated
with antibodies to BSA. Presumably this represented trace
amounts of BSA migrating with a Mr ￿68,000 that was
contaminating the original immunogen. Anti-BSA antibodies
were removed by passing antisera over a BSA affinity column.
The antibody that passed through in the void volume of this
column contained anti-epinectin antibodies that reacted by
ELISA with epinectin but not with BSA. Also, it should be
noted that BSA and epinectin are functionally quite distinct,
in that BSA does not promote cell adhesion and is commonly
used to inhibit nonspecific cell-substratum adhesion.
It is clear from other systems that some cells may produce
more than one noncollagenous glycoprotein involved in cell
attachment. For example, fibrosarcoma cells (9), NRK cells
(28), Schwannoma cells (19), among others produce both
laminin and fibronectin. Particular cells may use or produce
one molecule preferentially during different stages of devel-
opment or differentiation, in response to injury or in patho-
logical processes. The studies above describe a glycoprotein,
epinectin, which is very effective in promoting attachment of
A431 epithelial tumor cells. Consideration for this and other
yet undescribed glycoproteins should be given in examining
the attachmentofcellsof epithelial origin to various substrata
or basement membranes. The distribution of epinectin in
vivo, potential molecular interactions with other basement
membrane components, and possible biological roles other
than cell adhesion are currently under investigation.
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